{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:26:02Z","timestamp":1792787162107,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtcvs.2026.02.037","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:44:09Z","timestamp":1773391449000},"page":"600-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sodium-glucose cotransporter 2 inhibitor use and outcomes after surgical aortic valve replacement"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8421-0686","authenticated-orcid":false,"given":"Xander","family":"Jacquemyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irsa","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Serna-Gallegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bonatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kaczorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jtcvs.2026.02.037_bib1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jamacardio.2024.3486","article-title":"Aortic stenosis, heart failure, and aortic valve replacement","volume":"9","author":"Mengi","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.02.037_bib2","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.02.037_bib3","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"67","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jtcvs.2026.02.037_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014863","article-title":"Role of cardiac energetics in aortic stenosis disease progression: identifying the high-risk metabolic phenotype","volume":"16","author":"Monga","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"issue":"25","key":"10.1016\/j.jtcvs.2026.02.037_bib5","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jacc.2023.04.034","article-title":"Effect of SGLT2 inhibitors on cardiovascular outcomes across various patient populations","volume":"81","author":"Usman","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jtcvs.2026.02.037_bib6","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa2500366","article-title":"Dapagliflozin in patients undergoing transcatheter aortic-valve implantation","volume":"392","author":"Raposeiras-Roubin","year":"2025","journal-title":"New Engl J Med"},{"issue":"21","key":"10.1016\/j.jtcvs.2026.02.037_bib7","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"New Engl J Med"},{"issue":"16","key":"10.1016\/j.jtcvs.2026.02.037_bib8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.02.037_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jtcvs.2026.02.037_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jama.2025.20834","article-title":"SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria: a meta-analysis","volume":"335","author":"Neuen","year":"2026","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.02.037_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/STROKEAHA.120.031623","article-title":"Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease","volume":"52","author":"Zhou","year":"2021","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jtcvs.2026.02.037_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027764","article-title":"Sodium-glucose cotransporter-2 inhibitor prevents stroke in patients with diabetes and atrial fibrillation","volume":"12","author":"Chang","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.jtcvs.2026.02.037_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022222","article-title":"Sodium-glucose co-transporter inhibitors and atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Pandey","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.02.037_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jcin.2024.11.036","article-title":"Effect of sodium-glucose cotransporter-2 inhibitors on the progression of aortic stenosis","volume":"18","author":"Tayyab","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.02.037_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.02.037_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors","volume":"75","author":"Zelniker","year":"2020","journal-title":"JACC"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.02.037_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/cvr\/cvaf026","article-title":"Pre-ischaemic empagliflozin treatment attenuates blood\u2013brain barrier disruption via \u03b2-catenin mediated protection of cerebral endothelial cells","volume":"121","author":"Liu","year":"2025","journal-title":"Cardiovasc Res"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326007634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326007634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:39:49Z","timestamp":1791491989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522326007634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022522326007634"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.02.037","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose cotransporter 2 inhibitor use and outcomes after surgical aortic valve replacement","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}]}}